Pseudomonas cepacia, a Gram negative bacillus first de- scribed as a cause of soft rot in onions, is now recognised as an important opportunistic pathogen in altered hosts.' A distant relation of Pseudomonas aeruginosa, it is ubiquitous in the environment and frequently found in association with soil, water, and plants. It Others remain unconvinced of the pathogenicity and transmissibility of this organism. A carefully performed controlled study from a paediatric cystic fibrosis centre in Manchester, whilst not excluding the possibility of cross infection, found the introduction of segregation regrettable.22 A study from the UK's largest cystic fibrosis centre at the Royal Brompton Hospital found no evidence for patient-to-patient transmission although the authors accepted that nosocomial acquisition may have occurred. The Brompton patient group differs from that seen at most adult cystic fibrosis centres in that it is drawn from a much wider geographical base including overseas patients. The opportunity for social interactions outside hospital amongst these patients may therefore be less than in other centres. Indeed, it seems to be the case that the recent outbreaks of new Ps cepacia infections have occurred in centres whose patients participate in the most active social networks. 18 20 21 There is mounting evidence that some strains of Ps cepacia may be more transmissible and perhaps more pathogenic than others. In most of the reported UK outbreaks individual strains have been responsible for a large proportion of new infections within centres. Moreover, an individual strain has been implicated in outbreaks which may have occurred in several different centres supporting the notion of the importance of transmission occurring at regional, national, and perhaps international gatherings.'8 Evidence that Ps cepacia may act as more than an innocent bystander in those patients who experience an adverse outcome is seen from the high incidence of septicaemia as a terminal event in these patients. This has been a particular problem in patients with Ps cepacia infection undergoing transplantation and is in sharp distinction to patients colonised with Ps aeruginosa in whom septicaemia is rare. The current majority view is that, for a proportion of patients with cystic fibrosis, acquisition of Ps cepacia infection carries real risks of deterioration or premature death. Measures aimed at reducing acquisition, including segregation within the hospital environment and reduction of social contacts without, should be supported. These views are supported by guidelines from the ACFA23 and a recent European symposium.24 Acceptance and institution of these measures are not without their difficulties, and these issues were sensitively dealt with in a recent editorial. 25 Lastly, recognition of the existence of a problem has been hampered in some centres by failure to identify Ps cepacia in sputum specimens. Special laboratory techniques are required, especially if Ps cepacia infection coexists with Ps aeruginosa which rapidly overgrows Ps cepacia on non-inhibitory media. For many laboratories in the UK, especially those dealing with small numbers of cystic fibrosis specimens, these techniques may not be in regular use. Every physician dealing with cystic fibrosis patients should ensure the competence of their laboratory to isolate this pathogen.26 Universal and reliable recognition of the infection when present, together with common sense measures adopted to reduce transmission of this organism, should result in reduction of further spread and cessation of an epidemic which could yet cause further deaths amongst patients with cystic fibrosis.
